Pleural effusion as presentation of metastatic adenocarcinoma of prostate [7]

Southern Medical Journal

Volumn 98, Issue 9, 2005, Pages 959-960

  De Paso Mora, Pablo García ^a   Blanco, Juan José Ríos ^a   Pareja, Francisco José Pascual ^a   Torres, Carolina Castillo ^a   Marín, Álvaro Pinto ^a   Revuelta, África Sendino ^a   Rodríguez, Juan José Vázquez ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN; TRIPTORELIN;

AGED; BONE METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; GERIATRIC PATIENT; HUMAN; LETTER; MALE; MULTIMODALITY CANCER THERAPY; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA METASTASIS; PROSTATE ADENOCARCINOMA; THORAX RADIOGRAPHY;

ADENOCARCINOMA; AGED; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; PLEURAL EFFUSION, MALIGNANT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEINS;

EID: 25844438678     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000170725.86732.60     Document Type: Letter

References (5)

1. American Cancer Society. Cancer Facts and Figures 2003. Availablein: http://www.cancer.org/ downloads/STT/CAFF2003PWSecured.pdf. Accessed
2. Carrol PC, Lee KL, Fuks ZY. Cancer of the prostate. In: DeVita VT, Hellman S, eds. Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams and Wilkins, 6th ed, 2001, pp. 1418-1479,
3. Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagnostic Cytopathology 1996;15:103-107.
4. Rapaport Ah, Omenn GS. Dermatomyositis and malignant effusions: rare manifestations of carcinoma of the prostate. Journal of Urology 1968;100:183-187.
5. Cascinu S, Del Ferro, E, Barbani I, et al. Tumor markers in the diagnosis of malignant serous effusions. American Journal of Clinical Oncology 1997;20:247-250.